The report “High Content Screening Market by Instruments (Cell
Imaging and Analysis System), by Applications (Primary and Secondary Screening,
Target Identification and Validation, Toxicity Studies, Compound Profiling),
Software & Services – Global Forecasts to 2018″ by MarketsandMarkets is now available at RnRMarketResearch.com.
Contact sales@rnrmarketresearch.com with High
Content Screening Market by Instruments (Cell Imaging and Analysis System), by
Applications (Primary and Secondary Screening, Target Identification and
Validation, Toxicity Studies, Compound Profiling), Software & Services –
Global Forecasts to 2018 in subject line and your contact details to
purchase this report or get your questions answered.
The
global high content screening market is a technology-driven market and is
marked by the ‘Threat of Obsolescence,’ wherein technologies as well as their
adoption by end users changes very rapidly. Pharmaceutical and biotechnology
companies as well as academic and government institutes are increasingly
focusing on using high content screening as a powerful research tool in drug
discovery.
The
high content screening software market is the fastest-growing segment in the
high content screening market. In high content screening, the accuracy of the
results obtained depends on image analysis and data management software. In
recent years, enhanced image analysis and data management solutions have been
introduced, but there is scope for these solutions to be further improvised to
provide improved results. Many of the key players in the high content screening
instruments market are collaborating with software companies to offer products
with better software. For instance, in November 2010, PerkinElmer collaborated
with Glencoe Software, Inc. to integrate Columbus Scope, a cellular imaging
software solution for microscopy. With the data sharing facility, Columbus
Scope helps in data management in high content screening.
Request a Sample @ http://www.rnrmarketresearch.com/contacts/request-sample?rname=148396
.
In
the coming years, Asian countries are expected to witness a high growth. These
regions offer an array of opportunities for growth and are expected to be the
new revenue pockets for high content screening. This region offers a high
growth potential as compared to mature markets such as the U.S. Growth in the
Asian market is spurred by government support for the development of innovative
screening technologies and rising demand for outsourcing of drug discovery
services. For instance, in September 2013, Global Health Innovative Technology
Fund (GHIT Fund), granted $5.7 million to six global partnerships to support
the R&D activities of these partnerships in the area of various infectious
diseases like tuberculosis, malaria, and Chagas disease. Such fundings are
expected to boost the growth of the high content screening market.
The
global high content screening market is competitive and all the existing
players in this market are engaged in developing new and advanced products to
maintain their market shares.
Inquire a Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=148396
.
Reasons
to Buy the Report:
The
report will enrich both established firms as well as new entrants/smaller firms
to gauge the pulse of the market, which in turn would help the firms in
garnering a greater market share. Firms purchasing this report could use any
one or a combination of the below mentioned five strategies (market
penetration, product development/innovation, market development, market
diversification, and competitive assessment) for reaping a greater market
share.
The
report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios and services offered by the top players in the high content screening market. The report analyzes the high content screening market by application across geographies
- Product Development/Innovation: Detailed insights on research and development activities and new product launches in the high content screening market
- Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes promising applications of the high content screening market by product across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the high content screening market
- Competitive Assessment: In-depth assessment of market shares, strategies, products and services, and distribution networks in the high content screening market
Complete report spread across 151 pages available @ http://www.rnrmarketresearch.com/high-content-screening-market-by-instruments-cell-imaging-and-analysis-system-by-applications-primary-and-secondary-screening-target-identification-and-validation-toxicity-studies-compound-prof-market-report.html
.
Few Points from Table Of Contents
Company
Profiles
9.1 Becton,
Dickinson and Company
9.2 Cell Signaling Technology, Inc.
9.3 Danaher Corporation
9.4 Ge Healthcare (Subsidiary of General Electric Company)
9.5 Genedata Ag
9.6 Merck Kgaa
9.7 Perkinelmer, Inc.
9.8 thermo Fisher Scientific, Inc.
9.9 Thorlabs, Inc.
9.10 Yokogawa Electric Corporation
9.2 Cell Signaling Technology, Inc.
9.3 Danaher Corporation
9.4 Ge Healthcare (Subsidiary of General Electric Company)
9.5 Genedata Ag
9.6 Merck Kgaa
9.7 Perkinelmer, Inc.
9.8 thermo Fisher Scientific, Inc.
9.9 Thorlabs, Inc.
9.10 Yokogawa Electric Corporation
Buy a copy of report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=148396
.
For further information on “High
Content Screening Market by Instruments (Cell Imaging and Analysis System), by
Applications (Primary and Secondary Screening, Target Identification and
Validation, Toxicity Studies, Compound Profiling), Software & Services –
Global Forecasts to 2018” report OR for any other business research /
market intelligence need on the ‘Drug
Discovery’ market (http://www.rnrmarketresearch.com/reports/life-sciences/biotechnology/drug-discovery
.), contact
sales@rnrmarketresearch.com / Call +1 888 391 5441.
